Adverse Effects
50
2
5
38
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 50 trials
100.0%
+13.5% vs benchmark
20%
10 trials in Phase 3/4
13%
5 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (50)
Korea Comirnaty Post-marketing Surveillance
MAGIC Ruxolitinib for aGVHD
Effect of Remifentanil on Pruritus and Paresthesia of Fospropofol Disodium Anesthesia
Proactive Telemedicine to Improve Healthcare Access and Prevention in Rural Primary Care (PTM)
Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience
Effect of Probiotic Intake in Healthy Population
Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population
Prolonged Cryocompression and Skin Temperature: a Safety and Feasibility Pilot
Pediatric GVHD Low Risk Steroid Taper Trial
Self-Assessment Method for Statin Side-effects Or Nocebo
International Validation of the QLQ-OH17 for Oral Health
Systemic Adverse Effects After Osteopathic Treatment and Vitamin C
The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation
The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy
Emergency Department Crowding in Relation to In-hospital Adverse Medical Events
Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment
Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma
Genecept Assay and Adverse Effects of Antidepressants
How Safe Are Our Pediatric Emergency Departments?